1 buyer · 2 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 1 sold
Latest: purchase, 2026-08-19
Planned sales (Form 144), 90 days
$106.1K
1 notice
Costar insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, COSTAR GROUP, INC. insiders bought a net $4.8M of stock across 53 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Nov 13, 2025.
The trade is 25.4% of the 18,822 shares held after it.
1 other insider sold within 30 days.
422 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Cann Cynthia Cammett sold about $147.4K of CSGP on Aug 7, 2026; 1 other insider sold within 30 days and 422 funds added in the latest 13F quarter.
11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Nov 13, 2025.
The trade is 15.2% of the 22,993 shares held after it.
1 other insider sold within 30 days.
422 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hill John W sold about $105.7K of CSGP on Aug 5, 2026; 1 other insider sold within 30 days and 422 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (4 buys, 1 sale), the last on May 1, 2026.
-15.1% median (-14.3% mean) 90-day return after 3 previous buys.
The trade is 4.6% of the 1,806,165 shares held after it.
No other insider bought within 30 days.
422 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Founder and CEO FLORANCE ANDREW C bought about $2.5M of CSGP on Aug 4, 2026, the largest insider purchase at the company on our record; 422 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CSGP planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Hill John W
Filed 2026-08-05
$106.1K
CSGP mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Akre Focus ETF
$244.2M position · as of 2026-07-31
4.7%
Spyglass Growth Fund
$41.1M position · as of 2026-06-30
4.1%
Global X E-commerce ETF
$1.1M position · as of 2026-07-31
4.0%
VY(R) BARON GROWTH PORTFOLIO
$7.3M position · as of 2026-06-30
3.5%
Invesco S&P 500 Equal Weight Real Estate ETF
$2.7M position · as of 2026-07-31
2.7%
Polen Growth Fund
$44.0M position · as of 2026-07-31
2.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Andrew C. Florance
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$36.4M
$33.2M
$8.1M
+12%
+23%
2024
$37.4M
$8.2M
$8.2M
+20%
+19%
2023
$29.2M
$28.6M
$7.3M
+46%
+13%
2022
$19.4M
$16.2M
$5.6M
+29%
+1%
2021
$22.2M
$11.4M
$6.6M
+32%
+37%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $4.8M bought by insiders over 180 days, 422 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $106.1K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.6B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CSGP
FY Dec 2025
$3.2B
FY Dec 2024
$2.7B
FY Dec 2023
$2.5B
FY Dec 2022
$2.2B
FY Dec 2021
$1.9B
Jun 2026
$925.0M
Mar 2026
$897.0M
Dec 2025
$899.9M
Sep 2025
$833.6M
Jun 2025
$781.3M
Mar 2025
$732.2M
Dec 2024
$709.4M
Sep 2024
$692.6M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM CSGP
FY Dec 2025
n/a
FY Dec 2024
+5.1%
FY Dec 2023
+15.3%
FY Dec 2022
+16.9%
FY Dec 2021
+15.1%
Jun 2026
+5.9%
Mar 2026
+0.3%
Dec 2025
+5.1%
Sep 2025
-3.7%
Jun 2025
+0.8%
Mar 2025
-2.0%
Dec 2024
+8.4%
Sep 2024
+7.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
$280.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CSGP
FY Dec 2025
$123.0M
FY Dec 2024
-$186.0M
FY Dec 2023
$372.0M
FY Dec 2022
$443.5M
FY Dec 2021
$346.0M
Jun 2026
$77.0M
Mar 2026
$107.0M
Dec 2025
$101.3M
Sep 2025
-$5.3M
Jun 2025
$28.0M
Mar 2025
-$1.0M
Dec 2024
$25.6M
Sep 2024
$40.2M
At each fiscal year end
Single quarter
Debt to equity
0.13x
long-term 2026-06-30 plus current 2017-12-31 (103 months older than the period end); equity 2026-06-30
Debt to equity CSGP
FY Dec 2025
0.12x
FY Dec 2024
0.13x
FY Dec 2023
0.13x
FY Dec 2022
0.14x
FY Dec 2021
0.17x
Jun 2026
0.13x
Mar 2026
0.13x
Dec 2025
0.12x
Sep 2025
0.12x
Jun 2025
0.12x
Mar 2025
0.12x
Dec 2024
0.13x
Sep 2024
0.13x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.50x
TTM operating cash flow over long-term 2026-06-30 plus current 2017-12-31 (103 months older than the period end)
Cash flow to debt CSGP
FY Dec 2025
0.43x
FY Dec 2024
0.40x
FY Dec 2023
0.49x
FY Dec 2022
0.48x
FY Dec 2021
0.48x
Jun 2026
0.50x
Mar 2026
0.53x
Dec 2025
0.43x
Sep 2025
0.37x
Jun 2025
0.40x
Mar 2025
0.31x
Dec 2024
0.40x
Sep 2024
0.45x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on equity CSGP
FY Dec 2025
n/a
FY Dec 2024
+1.9%
FY Dec 2023
+5.3%
FY Dec 2022
+5.9%
FY Dec 2021
+5.3%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
+0.2%
Jun 2025
+1.3%
Mar 2025
+1.5%
Dec 2024
+1.9%
Sep 2024
+2.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on assets CSGP
FY Dec 2025
n/a
FY Dec 2024
+1.5%
FY Dec 2023
+4.3%
FY Dec 2022
+4.7%
FY Dec 2021
+4.1%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
+0.2%
Jun 2025
+1.1%
Mar 2025
+1.2%
Dec 2024
+1.5%
Sep 2024
+2.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital CSGP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
+7.0%
FY Dec 2022
+11.9%
FY Dec 2021
+11.2%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
+0.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+0.8%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CSGP
FY Dec 2025
-0.8%
FY Dec 2024
n/a
FY Dec 2023
+3.4%
FY Dec 2022
+6.0%
FY Dec 2021
+6.4%
Jun 2026
+0.8%
Mar 2026
-0.3%
Dec 2025
-0.8%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
+0.4%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
178.53x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CSGP
FY Dec 2025
6,724.00x
FY Dec 2024
204.54x
FY Dec 2023
94.99x
FY Dec 2022
83.10x
FY Dec 2021
106.80x
Jun 2026
149.05x
Mar 2026
672.33x
Dec 2025
6,724.00x
Sep 2025
1,687.40x
Jun 2025
321.60x
Mar 2025
273.21x
Dec 2024
204.54x
Sep 2024
171.45x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$13.5B
market value at close 2026-10-23 on 2026-07-27 shares, plus long-term 2026-06-30 plus current 2017-12-31 (103 months older than the period end), minus cash 2026-06-30
Enterprise value CSGP
FY Dec 2025
$27.9B
FY Dec 2024
$25.7B
FY Dec 2023
$31.5B
FY Dec 2022
$27.4B
FY Dec 2021
$28.4B
Jun 2026
$11.3B
Mar 2026
$16.7B
Dec 2025
$27.9B
Sep 2025
$34.8B
Jun 2025
$31.3B
Mar 2025
$29.8B
Dec 2024
$25.7B
Sep 2024
$26.7B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.0%
TTM free cash flow over market value at close 2026-10-23
FCF yield CSGP
FY Dec 2025
+0.4%
FY Dec 2024
-0.6%
FY Dec 2023
+1.0%
FY Dec 2022
+1.4%
FY Dec 2021
+1.1%
Jun 2026
+2.4%
Mar 2026
+1.4%
Dec 2025
+0.4%
Sep 2025
+0.1%
Jun 2025
+0.3%
Mar 2025
+0.2%
Dec 2024
-0.6%
Sep 2024
-0.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -24%, PEG needs growth
PEG, trailing CSGP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
3.24x
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CSGP ranks highest on growth (80th percentile) and insider conviction (77th), and lowest on risk and compliance (31st), among Services peers.
Financial health
70
Inputs
Debt to equity0.13x · 68 pct, sector of 228
Cash flow to debt0.50x · 71 pct, sector of 199
Growth
80
Inputs
Revenue growth, YoY+18.7% · 75 pct, sector of 341
Backlog growth, YoY+25.7% · 84 pct, sector of 77
Insider conviction
77
Inputs
Net Form 4 buying (codes P and S), 180d$4.8M · 97 pct, sector of 174
Insider buyers, 180d1 · 57 pct, sector of 179
Institutional and government
64
Inputs
Funds adding, latest quarter422 · 92 pct, sector of 243
Congress net buyers, 365d0 · 56 pct, sector of 37
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$630K · 45 pct, sector of 61
Risk and compliance
31
Inputs
Short interest, % of float+3.3% · 46 pct, sector of 383
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+23.6% · 15 pct, sector of 227
2 not measured: Profitability, US patents
Profitability needs 2 of 4 inputs, 1 present: tax provision or pre-tax income not filed for the four quarters; the filed year and its quarters do not reconcile, so the trailing figure is withheld
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CSGP filings, in plain words
Are Costar insiders buying or selling CSGP?
In the 180 days to 2026-10-27, Costar insiders were net buyers, a net $4.8M: $5.0M of purchases and $253.1K of sales reported on Form 4, by 1 buyer and 2 sellers.
Have members of Congress traded CSGP?
Yes. In the year to 2026-10-27, 1 House member disclosed buying CSGP and 1 House member disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-08-19.
Are there planned insider sales of CSGP?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $106.1K of stock; the latest, by Hill John W, was filed 2026-08-05.
Read the full summary
In the 180 days to 2026-10-27, Costar insiders were net buyers of CSGP, a net $4.8M across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. Purchases outweighed sales more than tenfold by value. In the year to 2026-10-27, 1 member of Congress disclosed buying CSGP and 1 member disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-08-19. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $106.1K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.